Insider: McCourt Marion EVP Commercial - REGENERON PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 12,931 | 0 | 12,931 |
| Value | $7,224,679.01 | $0.00 | $7,224,679.01 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 11/01/2024 | DDS | 1,000 | Direct | COM | $844.61 | $844,610.00 | 12,931 |
| 10/01/2024 | DDS | 1,000 | Direct | COM | $1,054.06 | $1,054,060.00 | 12,931 |
| 09/03/2024 | DDS | 1,000 | Direct | COM | $1,178.73 | $1,178,730.00 | 12,931 |
| 08/01/2024 | DDS | 1,137 | Direct | COM | $1,060.86 | $1,206,197.82 | 12,931 |
| 07/01/2024 | DDS | 1,137 | Direct | COM | $1,047.11 | $1,190,564.07 | 12,931 |
| 06/03/2024 | DDS | 1,138 | Direct | COM | $980.16 | $1,115,422.08 | 12,931 |
| 05/01/2024 | DDS | 250 | Direct | COM | $889.41 | $222,352.50 | 12,931 |
| 04/01/2024 | DDS | 250 | Direct | COM | $964.73 | $241,182.50 | 13,181 |
| 03/01/2024 | DDS | 358 | Direct | COM | $967.50 | $346,365.00 | 13,431 |
| 02/05/2024 | DDS | 1,000 | Direct | COM | $934.71 | $934,710.00 | 13,789 |
| 02/01/2024 | DDS | 273 | Direct | COM | $945.61 | $258,151.53 | 14,789 |
| 12/11/2023 | DDS | 270 | Direct | COM | $838.44 | $226,378.80 | 20,814 |
| 11/01/2023 | DDS | 1,000 | Direct | COM | $783.91 | $783,910.00 | 19,803 |
| 10/02/2023 | DDS | 1,038 | Direct | COM | $827.00 | $858,426.00 | 19,803 |
| 09/01/2023 | DDS | 250 | Direct | COM | $834.55 | $208,637.50 | 19,803 |
| 08/01/2023 | DDS | 250 | Direct | COM | $744.66 | $186,165.00 | 20,053 |
| 06/01/2023 | DDS | 250 | Direct | COM | $736.00 | $184,000.00 | 20,553 |
| 04/03/2023 | DDS | 1,100 | Direct | COM | $818.80 | $900,680.00 | 20,803 |
| 03/01/2023 | DDS | 1,100 | Direct | COM | $759.89 | $835,879.00 | 20,803 |
| 02/07/2023 | DDS | 1,000 | Direct | COM | $769.04 | $769,040.00 | 22,079 |
| 02/01/2023 | DDS | 1,100 | Direct | COM | $752.19 | $827,409.00 | 22,079 |
| 01/03/2023 | DDS | 1,100 | Direct | COM | $721.86 | $794,046.00 | 22,079 |
| 12/12/2022 | DDS | 264 | Direct | COM | $730.17 | $192,764.88 | 19,106 |
| 12/01/2022 | DDS | 1,100 | Direct | COM | $756.19 | $831,809.00 | 19,644 |
| 11/04/2022 | DDS | 1,000 | Direct | COM | $727.82 | $727,820.00 | 19,644 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research